Stay updated on ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page’s displayed software/version label has been updated from **Revision v3.5.2** to **Revision v3.5.3**, indicating an interface or site release update without affecting the underlying study record content.
    Difference
    0.0%
    Check dated 2026-04-24T17:10:19.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:41:07.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Added the new study title A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer (MUIR) and expanded the description of the Phase 1b study design, including Part 1 and Part 2, dose escalation and expansion with bevacizumab. Updated the page to Completed status with an enrollment target of 172 and a primary completion date of 2028-06-30, replacing the previous version.
    Difference
    3%
    Check dated 2026-04-10T08:55:19.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T20:46:54.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is now displayed, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-12T19:49:32.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the study's conditions, and the page revision was updated to v3.4.2 (v3.4.1 was removed).
    Difference
    0.1%
    Check dated 2026-02-12T01:39:54.000Z thumbnail image

Stay in the know with updates to ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ZN-c3 in Platinum-Resistant Ovarian Cancer Clinical Trial page.